NCT02475577

Determine Return on Investment in Heart Failure Remote Monitoring Program

A Prospective Randomized Controlled Trial to Determine Return on Investment in a Tablet/Smartphone-based Heart Failure Remote Monitoring Program

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 163 (estimated)
• Sponsor: NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCH · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Not accepted

Summary

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return on investment compared to remote monitoring with nurse researcher follow-up telephone communication to study subject (on Blue alerts) or study subject's healthcare professional (on Red alerts) (Intervention 2) and self-monitoring without intervention (Control).

Detailed description

The objective of this remote monitoring study is to evaluate return on investment and end-user clinical outcomes associated with the use of self-monitoring peripherals and tablet/smartphone-based Welch Allyn HealthInterlink technology without intervention (Control), HealthInterlink remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1), and HealthInterlink remote monitoring with nurse research assistant follow-up telephone communication to study subject (on Blue alerts) or study subject's healthcare professional (on Red alerts) (Intervention 2 added to Intervention 1).

Conditions

• Heart Failure

Interventions

Type	Name	Description
DEVICE	Peripherals with HealthInterlink technology	home remote monitoring

Timeline

• Start date: 2015-06-01
• Primary completion: 2017-06-01
• Completion: 2017-08-01
• First posted: 2015-06-18
• Last updated: 2016-03-31

Locations

1 site across 1 country: United States